Abacus Global Management

ABX · NYSE

$8.39+$0.54 (+6.88%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $7.85

ABX analyst rating

HoldConsensus of 1 analyst over the last 12 months. 0% rate it a buy.

Strong buy0
Buy0
Hold1
Underperform0
Sell0

12-month price target · 8 analysts

Average $14.64 (+74.5% upside)

Low: $12.12
Now: $8.39
High: $16.80

Upgrades and downgrades

The latest rating actions, newest first

ABX analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Piper Sandler	Oct 19, 2026	Maintains	Neutral	$12.00 → $10.00	37%
Piper Sandler	Aug 7, 2026	Maintains	Neutral	$13.00 → $12.00	37%
Piper Sandler	Jul 13, 2026	Maintains	Neutral	$10.00 → $13.00	37%
Piper Sandler	May 8, 2026	Maintains	Neutral	$9.50 → $10.00	37%
Piper Sandler	Apr 7, 2026	Maintains	Neutral	$11.00 → $9.50	37%
Piper Sandler	Mar 13, 2026	Downgrade	Overweight → Neutral	$11.00	37%

The case for and against

Updated Oct 18, 2026

Bull case

Abacus Global Management is supported by a stronger-than-expected earnings profile, with 2Q26 adjusted EPS of $0.28 above both PSC’s $0.25 and the Street’s $0.24, while adjusted EBITDA of $39.9M and a 55% margin underscore durable profitability. Its raised 2026 adjusted net income guidance of $100M to $106M, up from $96M to $104M, implies 18% to 24% annual growth and suggests management sees continued momentum across its life solutions and related businesses. The slightly above-Street 3Q26 outlook, combined with a “fairly robust” acquisition pipeline and selective, accretive M&A discipline, reinforces confidence in sustained fundamental expansion.

Bear case

Abacus Global Management is viewed negatively because, despite a modest EPS beat, the quarter showed softer underlying revenue than expected, suggesting earnings strength was aided more by expense control and a lower share count than by robust top-line momentum. Adjusted EBITDA of $32.7M also fell slightly below estimates, and the 55% margin, while strong, did not fully offset concerns that the company’s core growth engine remains uneven. With the majority of revenue tied to the Life Solutions segment and policy-related transactions, any slowdown in deal flow or policy activity can weigh on sustainability and overall fundamental quality.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.